Susquehanna International Group, LLP Cytokinetics Inc Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Cytokinetics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 539,110 shares of CYTK stock, worth $19.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

539,110

Previous 139,117 287.52%

Holding current value

$19.5 Million

Previous $6.54 Million 231.08%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$40.19 - $51.12 $16.1 Million - $20.4 Million	399,993 Added 287.52%	539,110 $21.7 Million
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $2.89 Million - $3.66 Million	-62,372 Reduced 30.96%	139,117 $6.54 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $2.28 Million - $2.67 Million	44,450 Added 28.31%	201,489 $10.6 Million
Q2 2024 Aug 15, 2024	SELL	$47.86 - $75.05 $20.1 Million - $31.5 Million	-419,438 Reduced 72.76%	157,039 $8.51 Million
Q1 2024 May 07, 2024	SELL	$63.75 - $108.06 $3.76 Million - $6.38 Million	-59,025 Reduced 9.29%	576,477 $40.4 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $12.7 Million - $39.3 Million	470,916 Added 286.12%	635,502 $53.1 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $1.72 Million - $2.14 Million	58,529 Added 55.19%	164,586 $4.85 Million
Q2 2023 Aug 11, 2023	SELL	$32.62 - $40.75 $1.01 Million - $1.27 Million	-31,057 Reduced 22.65%	106,057 $3.46 Million
Q1 2023 May 16, 2023	BUY	$33.36 - $45.71 $3.48 Million - $4.76 Million	104,204 Added 316.63%	137,114 $4.83 Million
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $985,856 - $1.41 Million	-27,561 Reduced 45.58%	32,910 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.52 Million - $2.15 Million	39,490 Added 188.22%	60,471 $2.93 Million
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $855,952 - $1.23 Million	-25,227 Reduced 54.59%	20,981 $824,000
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $2.14 Million - $3.31 Million	-72,052 Reduced 60.93%	46,208 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $128,503 - $173,507	3,741 Added 3.27%	118,260 $5.39 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $630,211 - $1.21 Million	33,992 Added 42.21%	114,519 $4.09 Million
Q2 2021 Aug 11, 2021	BUY	$19.79 - $26.99 $515,331 - $702,819	26,040 Added 47.79%	80,527 $1.59 Million
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $17,010 - $23,522	916 Added 1.71%	54,487 $1.27 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $4.56 Million - $8.55 Million	-298,812 Reduced 84.8%	53,571 $1.11 Million
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $5.56 Million - $7.82 Million	270,015 Added 327.82%	352,383 $7.63 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $362,977 - $802,130	32,554 Added 65.35%	82,368 $1.94 Million
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $745,272 - $1.39 Million	-85,174 Reduced 63.1%	49,814 $587,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $214,506 - $319,466	-26,982 Reduced 16.66%	134,988 $1.43 Million
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $413,572 - $544,677	38,223 Added 30.89%	161,970 $1.84 Million
Q2 2019 Aug 16, 2019	BUY	$7.95 - $11.25 $65,849 - $93,183	8,283 Added 7.17%	123,747 $1.39 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $434,737 - $615,195	54,684 Added 89.97%	115,464 $1.3 Million
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $142,395 - $223,833	24,094 Added 65.68%	60,780 $384,000
Q2 2018 Aug 14, 2018	BUY	$6.9 - $9.9 $253,133 - $363,191	36,686 New	36,686 $304,000

Others Institutions Holding CYTK

# of Institutions

399

Shares Held

128M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.41B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cytokinetics Inc Transaction History